Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study. (Q33410236)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study. |
scientific article |
Statements
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: a European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study (English)
Birgit Geoerger
Nathalie Dias-Gastellier
Annick Devos
Kieran Mc Hugh
Ariane Boubaker
Arnaud Verschuur
Stéphane Ducassoul
Katty Malekzadeh
Loredana Amoroso
Pascal Chastagner
Christian M Zwaan
Caroline Munzer
Judith Landman-Parker
7 September 2013